Literature DB >> 10651938

Mucosal immunogenicity of plant lectins in mice.

E C Lavelle1, G Grant, A Pusztai, U Pfüller, D T O'Hagan.   

Abstract

The mucosal immunogenicity of a number of plant lectins with different sugar specificities was investigated in mice. Following intranasal (i.n.) or oral administration, the systemic and mucosal antibody responses elicited were compared with those induced by a potent mucosal immunogen (cholera toxin; CT) and a poorly immunogenic protein (ovalbumin; OVA). After three oral or i.n. doses of CT, high levels of specific serum antibodies were measured and specific IgA was detected in the serum, saliva, vaginal wash, nasal wash and gut wash of mice. Immunization with OVA elicited low titres of serum IgG but specific IgA was not detected in mucosal secretions. Both oral and i.n. delivery of all five plant lectins investigated ¿Viscum album (mistletoe lectin 1; ML-1), Lycospersicum esculentum (tomato lectin; LEA), Phaseolus vulgaris (PHA), Triticum vulgaris (wheat germ agglutinin (WGA), Ulex europaeus I (UEA-1) stimulated the production of specific serum IgG and IgA antibody after three i. n. or oral doses. Immunization with ML-1 induced high titres of serum IgG and IgA in addition to specific IgA in mucosal secretions. The response to orally delivered ML-1 was comparable to that induced by CT, although a 10-fold higher dose was administered. Immunization with LEA also induced high titres of serum IgG, particularly after i. n. delivery. Low specific IgA titres were also detected to LEA in mucosal secretions. Responses to PHA, WGA and UEA-1 were measured at a relatively low level in the serum, and little or no specific mucosal IgA was detected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651938      PMCID: PMC2327126          DOI: 10.1046/j.1365-2567.2000.00932.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Identification of intact peanut lectin in peripheral venous blood.

Authors:  Q Wang; L G Yu; B J Campbell; J D Milton; J M Rhodes
Journal:  Lancet       Date:  1998-12-05       Impact factor: 79.321

2.  Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae.

Authors:  W Van den Broeck; E Cox; B M Goddeeris
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  The influence of diets and gut microflora on lectin binding patterns of intestinal mucins in rats.

Authors:  R Sharma; U Schumacher
Journal:  Lab Invest       Date:  1995-10       Impact factor: 5.662

4.  Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

Review 5.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

6.  Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.

Authors:  M Ugozzoli; D T O'Hagan; G S Ott
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

Review 7.  Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.

Authors:  N A Williams; T R Hirst; T O Nashar
Journal:  Immunol Today       Date:  1999-02

8.  Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Authors:  G Douce; C Turcotte; I Cropley; M Roberts; M Pizza; M Domenghini; R Rappuoli; G Dougan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

Authors:  M Pizza; M Domenighini; W Hol; V Giannelli; M R Fontana; M M Giuliani; C Magagnoli; S Peppoloni; R Manetti; R Rappuoli
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

10.  Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.

Authors:  G Douce; M M Giuliani; V Giannelli; M G Pizza; R Rappuoli; G Dougan
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

View more
  14 in total

Review 1.  Bioadhesion: new possibilities for drug administration?

Authors:  J Woodley
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  The identification of plant lectins with mucosal adjuvant activity.

Authors:  E C Lavelle; G Grant; A Pusztai; U Pfüller; D T O'Hagan
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

3.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

4.  Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice.

Authors:  Jue Hou; Ying Liu; Jenny Hsi; Hongzhi Wang; Ran Tao; Yiming Shao
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

5.  Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

Authors:  E C Lavelle; G Grant; A Pusztai; U Pfüller; O Leavy; E McNeela; K H G Mills; D T O'Hagan
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

Review 6.  Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus.

Authors:  Arbind Kumar; Aashish Sharma; Narendra Vijay Tirpude; Yogendra Padwad; Vipin Hallan; Sanjay Kumar
Journal:  Pharmacol Rep       Date:  2022-09-20       Impact factor: 3.919

Review 7.  Enhancing oral vaccine potency by targeting intestinal M cells.

Authors:  Ali Azizi; Ashok Kumar; Francisco Diaz-Mitoma; Jiri Mestecky
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

Review 8.  Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.

Authors:  Gunver S Kienle; Renate Grugel; Helmut Kiene
Journal:  BMC Complement Altern Med       Date:  2011-08-28       Impact factor: 3.659

Review 9.  Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

Authors:  Amy Corbin Farr; May P Xiong
Journal:  Mol Pharm       Date:  2020-10-09       Impact factor: 4.939

10.  Novel animal defenses against predation: a snail egg neurotoxin combining lectin and pore-forming chains that resembles plant defense and bacteria attack toxins.

Authors:  Marcos Sebastián Dreon; María Victoria Frassa; Marcelo Ceolín; Santiago Ituarte; Jian-Wen Qiu; Jin Sun; Patricia E Fernández; Horacio Heras
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.